Liver NeoplasmsMeningeal NeoplasmsMeningioma
Dr. Mohammad Pazooki, MD
NPI1881851616PAC ID9436220761
- Medicare services, 2024
- 8,704
- Medicare patients, 2024
- 355
- Part D claims, 2024
- 988
- Publications
- 1
- MIPS score, 2024
- 86
- Practice address
- 500 Frank W Burr Blvd, Teaneck, NJ 07666
- Practice phone
- Call (860) 533-3091
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Regional Cancer Care Associates
Teaneck, New Jersey
Find Dr. Pazooki's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mohammad Pazooki is a hematologist and oncologist in Teaneck, New Jersey
Dr. Pazooki practices at Regional Cancer Care Associates in Teaneck, New Jersey.
Dr. Pazooki's NPI, 1881851616, was assigned on May 20, 2008. Dr. Pazooki holds Connecticut license 047129.
NPI and contact details
- NPI
- 1881851616NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9436220761
- NPI enumeration date
- May 20, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (860) 533-3091
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mohammad Pazooki practices at Regional Cancer Care Associates in Teaneck, New Jersey
Dr. Pazooki's primary practice is Regional Cancer Care Associates, at 500 Frank W Burr Blvd, Teaneck, NJ 07666 in Bergen County. The practice phone is (860) 533-3091.
- Regional Cancer Care Associates500 Frank W Burr Blvd, Teaneck, NJ 07666 · Bergen CountyPhone(860) 533-3091
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Mohammad Pazooki is affiliated with 4 sites of care and 1 medical group
Dr. Pazooki's primary practice is Regional Cancer Care Associates in Teaneck, New Jersey. Dr. Pazooki is also affiliated with Saint Francis Hospital. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. Pazooki to 1 more hospital and 1 group practice or clinic, each named with a free account.
Regional Cancer Care AssociatesPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mohammad Pazooki's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pazooki practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Regional Cancer Care Associates | Available with a free account |
| +3 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Pazooki practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mohammad Pazooki is one of 364 hematologists and oncologists in New Jersey
Hematology and oncology is Dr. Pazooki's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pazooki is licensed in Connecticut.
Specialties and state licenses
- Hematology and oncology, ConnecticutPrimary
Hematologists and oncologists near Dr. Pazooki
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mohammad Pazooki billed Medicare for 8,704 services in 2024
CMS data shows 8,704 Medicare services from Dr. Pazooki across 20 procedure codes in 2024, for 355 Medicare patients. Medicare paid $171,370 for them.
Medicare services, 20248,704
Medicare patients355
Paid by Medicare$171,370
Procedure codes20
Dr. Pazooki's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 10,5562024: 4,06961%
- Other services
- 2023: 3,0612024: 3,2807%
- Office and hospital visits
- 2023: 7822024: 7662%
- Tests and treatments
- 2023: 8002024: 58926%
Where Dr. Pazooki's Medicare services took place, 2024
- In an office8,690100%
- In a facility140%
Dr. Pazooki compared with the New Jersey median for hematologists and oncologists, 2024
- Dr. Pazooki
- New Jersey median
- Medicare services
- 8,704vs 1,5155.7 times
- Medicare patients
- 355vs 3375% above
- Part D claims
- 836vs 3782.2 times
Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.
Dr. Pazooki's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Pazooki?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Pazooki and other hematologists and oncologists in New Jersey.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mohammad Pazooki treated 355 Medicare patients in 2024, average age 77
CMS counts 355 Medicare patients who saw Dr. Pazooki in 2024. The largest group is 75 to 84, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Pazooki's median patient age at 74, with 57% women.
Medicare patients, 2024355
Average age77
Average risk score2.02
Also on Medicaid20%
Dr. Pazooki's Medicare patients by age, 2024
Dr. Pazooki's Medicare patients by sex, 2024
- Women19755%
- Men15845%
Chronic conditions among Dr. Pazooki's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis44%
- Chronic kidney disease40%
- Diabetes38%
- Ischemic heart disease38%
- Cancer34%
- Anxiety30%
Share of Medicare patients with each condition. A patient can have several.
Dr. Pazooki's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women57%
- Men41%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mohammad Pazooki wrote 988 Medicare Part D claims in 2024
In 2024, Dr. Pazooki wrote 988 Medicare Part D claims for 200 patients. 52% of them were for generic drugs. CMS names the drug for 836 of them, across 30 drugs with 11 or more claims each, at $3,885,827 in total drug cost. In 2023, CMS named 650 claims across 21 drugs.
Part D claims, 2024988
Drugs named by CMS30
Total drug cost$3.9M
Part D patients200
Dr. Pazooki's Part D claims by kind of drug, 2024
- Generic515 claims52%
- Brand-name473 claims48%
Dr. Pazooki's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Pazooki's Part D claims, 2024
- Opioids1%12 of 988 claims
- Antibiotics2%18 of 988 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6502024: 83629%
Drugs named by CMS: 30 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mohammad Pazooki scored 86 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Pazooki for performance year 2024, reported individually. Dr. Pazooki accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Pazooki's MIPS scores, performance year 2024
- 86of 100Final score
- 61.9of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Pazooki by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mohammad Pazooki has 1 publication on record
Dmand AI links 1 paper to Dr. Pazooki in 2010. Dr. Pazooki's most frequent co-authors are Murtuza M. Rampurwala and Peter K. Schauer, MD.
Papers1
Dr. Pazooki's most frequent co-authors
Recent publications by Dr. Pazooki
See who Dr. Pazooki researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Pazooki works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mohammad Pazooki received $9,476 in industry payments from 2016 to 2024
CMS Open Payments shows 531 general payments to Dr. Pazooki from 58 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 86% of the total. Janssen Pharmaceuticals, Inc paid the most, $719.
General payments to Dr. Pazooki by program year, 2016 to 2024
General payments to Dr. Pazooki by kind, 2016 to 2024
$9.5Kin total
- Food and beverage$8,12686%
- Education$95010%
- Consulting fees$4004%
Companies that paid Dr. Pazooki the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Mohammad Pazooki's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mohammad Pazooki
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mohammad Pazooki's NPI number?
Dr. Mohammad Pazooki's NPI number is 1881851616. It was assigned on May 20, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Mohammad Pazooki?
Dr. Mohammad Pazooki is a hematologist and oncologist in Teaneck, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Mohammad Pazooki practice?
Dr. Pazooki practices at 500 Frank W Burr Blvd, Teaneck, NJ 07666. Dr. Pazooki's primary practice is Regional Cancer Care Associates in Teaneck, New Jersey. Dmand AI also links Dr. Pazooki to 1 hospital and 1 group practice or clinic.
What is Dr. Mohammad Pazooki's office phone number?
The practice phone on file for Dr. Pazooki is (860) 533-3091.
What is Dr. Mohammad Pazooki's medical license number?
Dr. Pazooki holds Connecticut license 047129.
Which hospitals is Dr. Mohammad Pazooki affiliated with?
Dr. Pazooki is affiliated with Saint Francis Hospital. Dmand AI links Dr. Pazooki to 1 more hospital.
What medical group is Dr. Mohammad Pazooki part of?
Dr. Pazooki is linked to Regional Cancer Care Associates.
Does Dr. Mohammad Pazooki accept Medicare?
Yes. CMS data shows Dr. Pazooki billed Medicare for 8,704 services in 2024, and Dr. Pazooki accepts Medicare assignment.
What is Dr. Mohammad Pazooki's MIPS score?
Dr. Pazooki's MIPS final score for performance year 2024 is 86 out of 100, reported individually.
How many Medicare patients does Dr. Mohammad Pazooki see?
CMS counts 355 Medicare patients who saw Dr. Pazooki in 2024, with an average age of 77.
Show 6 more questionsShow fewer questions
What services does Dr. Mohammad Pazooki bill to Medicare?
In 2024, Dr. Pazooki's most billed Medicare services were medicare temporary code (Q5106), injected or infused drug (J0897) and injected or infused drug (J1437).
What drugs does Dr. Mohammad Pazooki prescribe most?
In 2024 Medicare Part D data, Dr. Pazooki's most prescribed drugs by claims were Eliquis, Hydroxyurea and Xarelto.
Has Dr. Mohammad Pazooki received payments from drug or device companies?
CMS Open Payments shows $9,476 in general payments to Dr. Pazooki from 58 companies from 2016 to 2024. The largest total came from Janssen Pharmaceuticals, Inc.
How long has Dr. Mohammad Pazooki been practicing?
Dr. Pazooki graduated from medical school in 1995, 31 years ago.
Does Dr. Mohammad Pazooki do research?
Dmand AI links 1 publication to Dr. Pazooki.
Who does Dr. Mohammad Pazooki publish with?
Dr. Pazooki's most frequent co-authors are Murtuza M. Rampurwala (1 shared paper) and Peter K. Schauer, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card